Cite

HARVARD Citation

    Awah, C. et al. (2022). Genome-scale CRISPR Cas9a knockout screen reveals genes that control glioblastoma susceptibility to the alkylating agent temozolomide. All life. 15 (1), pp. 88-93. [Online]. 
  
Back to record